---
title: "Shanghai Pharmaceuticals Revises Vote Data on 2025 Profit Distribution Plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292068693.md"
description: "Shanghai Pharmaceuticals Holding Co., Ltd. issued a clarification correcting the voting results for its 2025 profit distribution plan. The revised data shows significantly lower support among A-share investors, with many voting against the plan, while H-share holders remain largely in favor. This correction does not affect other original announcement details but may lead to increased scrutiny of shareholder sentiment and governance disclosures."
datetime: "2026-07-08T12:07:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292068693.md)
  - [en](https://longbridge.com/en/news/292068693.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292068693.md)
generator: "portal-rs"
---

# Shanghai Pharmaceuticals Revises Vote Data on 2025 Profit Distribution Plan

Shanghai Pharmaceuticals Holding Co., Ltd. has issued a clarification to its earlier disclosure on the voting results for its 2025 profit distribution plan at the annual general meeting. The company corrected the reported vote breakdown for A share and total ordinary share holders, noting that the clarification does not affect any other information in the original announcement.

The revised figures show substantially lower support among A share investors for the proposed profit distribution plan than previously reported, with a significant proportion voting against. While H share holders remain almost unanimously in favour, the corrected data may prompt closer scrutiny of shareholder sentiment and governance disclosures at the company.

**More about Shanghai Pharmaceuticals Holding Co**

Shanghai Pharmaceuticals Holding Co., Ltd. is a major Chinese pharmaceutical group engaged in the manufacture, distribution and retail of medicines and healthcare products. Listed in Hong Kong, the company serves both A share and H share investors and plays a significant role in China’s healthcare supply chain and pharmaceutical market.

**Average Trading Volume:** 3,315,475

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** HK$64.01B

Learn more about 2607 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [02607.HK](https://longbridge.com/en/quote/02607.HK.md)
- [601607.CN](https://longbridge.com/en/quote/601607.CN.md)

## Related News & Research

- [Shanghai Pharmaceuticals AGM Secures Strong Shareholder Backing and Governance Stability](https://longbridge.com/en/news/290840513.md)
- [Shanghai Pharma signs strategic R&D partnership with CAS Shanghai Institute of Materia Medica](https://longbridge.com/en/news/298383149.md)
- [VNET Completes Strategic Investment, New Shareholder Group Takes 38.1% Stake](https://longbridge.com/en/news/299632633.md)
- [Michael Saylor Says, 'A Little More Orange': Will Strategy Report BTC Purchases After Hitting Pause for 3 Weeks?](https://longbridge.com/en/news/299601303.md)
- [Tesla Roadster Speculation Grows After FAA Sets 10,000-Foot Airspace Restriction](https://longbridge.com/en/news/299677194.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**